EPH156 Modelling Herpes Zosters Burden and Public Health Impact of Adjuvanted Recombinant Zoster Vaccine Among Adults Aged ≥50 Years Old in Seven Countries in Central and South America
Abstract
Authors
R. Han A. Guzman-Holst J. Gómez L. Naranjo T. Rosales D. van Oorschot